Skip to main content
. 2022 Apr 15;20(4):482–494. doi: 10.5217/ir.2021.00161

Fig. 1.

Fig. 1.

Study flow of patients treated with anticoagulants. (A) Overall patients (the overall cohort) and (B) subgroup patients who underwent polypectomy (post-polypectomy cohort). GIB, gastrointestinal bleeding; NOACs, non-vitamin K antagonist oral anticoagulants.